2005 till today

 

i  Foundation of the daugther comany terraplasma medical GmbH together with the company Dynamify GmbH.

D  Grant of the patent "Plasma source" in Europe. (Nationlization in DE, FR and GB). This patent protects the Venturiplasma technology.

i  Start of the cooperation project "Cold plasma device for the treatment of chronic and acute wounds" funded by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology.

i  Start of the cooperation project "Plasma decontamination of sensitive space flight components" funded by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology.

i  Start and successful completion of the project "Investigation of a handheld device for plasma disinfection" funded by the Space Agency of the German Aerospace Center.

D  Patent application "Plasma aktiviertes Wasser zur Dekontamination von Zahnprothesen und zum Bleichen von Zähnen" in Germany. This patent application protects the activation of water with cold atmospheric plasma for decontamination of dentures and teeth bleaching.

i  Successful completion of the development of a technology demonstrator for the decontamination of thermolabile equipment for the Bundeswehr Research Institute for Protective Technologies and NBC Protection (WIS).

i  Start of the project „A cold plasma device to support future manned spaceflight” with the European Space Agency (ESA).

 

i  Plasma device "SteriPlas" for the treatment of chronic wounds is introduced to the market by our cooperation partner Adtec Ltd.

i  Licensing of the plasma technology based on the patent "plasma source"  to our cooperation partner Adtec Ltd.

i  ISO 9001 and 13485 certification.

i  Start of our new webpage in April.

i  Increase of permanent staff members from 6 to 9.

D  Patent application "Vorrichtung und Verfahren zum Erzeugen eines Plasmas, sowie Verwendung einer solchen Vorrichtung". This patent application protects a magnetic organized plasma source which very efficiently destroys odour molecules.

D  Patent application "Elektrodenanordnung und Plasmaquelle zur Erzeugung eines nicht-thermischen Plasmas sowie ein Verfahren zum Betreiben einer Plasmaquelle". This application protects the thin film technology, which is based on the Surface Micro-Discharge technology.

D  Grant of the patent "Electrode arrangement for generating a non-thermal Plasma" in Japan. This patent protects the Surface Micro-discharge technology.

D  Grant of the patent "Desinfektionseinrichtung, Behälter, Verwendung eines Behälters und Desinfektionsverfahrens zur Desinfektion eines Behälters, insbesondere für einen Lebensmittelbehälter" in Europe (Nationlization in DE, FR and GB).

D  Grant of the patent "Plasma source" in Europe.

D  Release of three scientific publications.

G  Development of a technology demonstrator for the decontamination of thermolabile equipment

 

D  Grant of the patent "Plasma source" in USA and Japan. This patent protects the Venturiplasma technology.

D  Release of six scientific publications.

i  PD Dr. Julia Zimmermann is appointed CEO.

i  Increase of permanent staff members from 2 to 6.

i  Additional team support by recruiting several interns and trainees.

i  Extension of our microbiological laboratory through acquisition of the laboratory equipment from the Max Planck Institute for Extraterrestrial Physics.

i  Successful completion of the world's first clinical trials for chronic and acute wounds and herpes zoster with cold atmospheric plasma. 

G  Development of the thin-film electrode - an evolution of the Surface Micro-Discharge and Self-Sterilizing Surface technology.

G  Development of a technology demonstrator for the disinfection of dental instruments.

G  Development of a technology demonstrator for the disinfection of water with cold atmospheric plasma.

 

i  Prof. Dr. Dr. h.c. Gregor Morfill retires from MPE and is appointed CEO.

i  Expansion of business activities by implementing a Biosafety-Level-1-Laboratory. 

i  Expansion of the clinical trials on Herpes Zoster (Shingles).

G  Development of a small mobile battery-powered plasma device. 

D  Release of 14 scientific publications

 

i  terraplasma obtains office and laboratory space in "Garchinger Technologie- und Gründerzentrum" (Gate Garching).

D  Release of 17 scientific publications

 

i  terraplasma GmbH was founded in May 2011 as a spin-off of the Max Planck Society - the Max-Planck Society represented by Max Planck Innovation GmbH became a significant shareholder.

i  Selected shareholders with subsequent employment in the company are:

− Prof. Dr. Dr. h.c. Gregor Morfill (Physicist and Director at the Max-Planck Institute Extraterrestrial Physics) 
− PD Dr. Julia Zimmermann (Biophysicist and team leader for Plasma Medicine at the Max-Planck Institute for Extraterrestrial Physics) 
− Dr. Tetsuji Shimizu (Electrical Engineer and Plasma Physicist) 
− Dr. Yangfang Li (Development Engineer and Plasma physicist) 
Max Planck Society

i  Expansion of clinical trials on acute wounds.

D  Patent application "Vorrichtung und Verfahren zur Plasmabehandlung von Oberflächen, sowie Verwendung einer Vorrichtung/Device and method for the plasma treatment of surfaces and use of a device" in USA and EU.

D  Patent application "Verfahren zur Inaktivierung vorzugsweise geruchsrelevanter Moleküle und Vorrichtung zu dessen Durchführung/Method for deactivating preferably odour-relevant molecules and device for carrying out said method" in USA and EU.

D  Patent application "Desinfektionseinrichtung, Behälter, Verwendung eines Behälters und Desinfektionsverfahrens zur Desinfektion eines Behälters, insbesondere für einen Lebensmittelbehälter" in EU.

D  Release of seven scientific publications.

 

D  Grant of patent "Plasma sorce" in the USA.

D  Patent application "Method and arrangement for treating an object with a low-temperature plasma" in USA.

D  Patent application for the Self-Sterilizing Surface Plasma Technology: "Disinfection appliance and disinfection method" in USA and EU.

D  Patent application "Method and arrangement for treating an object with a low-temperature plasma" in USA.

D  Release of four scientific publications. 

G  Development of the so-called Self-Sterilizing Surface Technology (SSS) – incorporating a fully encapsulated micro plasma electrode.

D  Patent application "Electrode Arrangement for generating a non-thermal plasma" in USA, EU, China and Japan.

D  Release of five scientific publications

G  Development of the "Micro Plaster β" - an optimized and smaller version of the "Micro Plaster α".

G  Use of "Micro Plaster β" in the clinical trials for chronic wounds.

G  Development of the microplasma technology (Surface Micro-Discharge Technology)

D  First scientific publication.

D  Patent application: "Electrode Arrangement for generating a non-thermal plasma" in USA, JP and EU. 

 

D  Patent application "plasma source"  in USA, EU and RU.

G  Beginning of clinical trials for the treatment of chronic wounds with the "MicroPlaSter α" - a plasma device developed in collaboration between the Max Planck Institute for Extraterrestrial Physics and Adtec Ltd.

G  Development of the Venturiplasma technology